Research News - February 7, 2020

The "Science as Art Exhibit" will showcase the science-inspired artistic works of Mass General researchers. 

Selected pieces will be on display in the lobby of Building 149 for one month starting in late March, after which they will be relocated to adorn the CNY114 and CNY149 Buildings as part of our permanent collection. 

Great examples of art to submit include microscopic images, artist renderings of science, and failed/successful cover art images for journals.

Each image should be submitted in JPEG or TIF format at a minimum 300 dpi resolution and rendered at 16”x20”.  Selected images will be printed onto framed canvas.  Images should be copyright free and devoid of attribution text, signatures by artists, or embedded title of the art work. 

We hope to showcase up to 100 art pieces from our researcher community across the MGH campus, so please submit multiple pieces for consideration!  

Submissions will be accepted until February 28th, 2020 using the following link:
https://forms.gle/qsSZHLyfUfbLGD5T9

The CNY Quality of Life Committee, MGRI, and ECOR

The Post Doctoral Division’s Research Fellow Poster Celebration will take place on May 7, 2020. The annual Poster Celebration highlights the excellent research being done by MGH research fellows. The Call for Abstracts is now open! All MGH research fellows are invited to submit their research abstracts now to present their research to the MGH community at this high-profile event. Abstracts/posters will be evaluated by a review committee, and the top presentations will receive awards and cash prizes.

Abstracts are due at 4:00 pm on Fri, Feb 28.

Please click here for abstract guidelines.

Email pdd@partners.org with questions about the Poster Celebration.

For the latest updates, please visit: http://apollo.massgeneral.org/coronavirus/

This month, Microsoft introduces patches for critical flaws and vulnerabilities that require you to patch as soon as possible. If you use a non-standard Windows or personally-owned device for Partners' business, it is your responsibility to keep your device and software up to date. If you use a Partners Standard Windows Computer, your system has been patched. See HOWTO: Run Windows Updates for additional instructions. Please contact the IS Service Desk if you have any questions or concerns.

Click here to read the latest news from the Office of Extramural Research.

To ensure premium supportability, security and performance, ERIS strives to keep all systems up to their most current and/or stable revisions. To minimize disruption, ERIS will complete all non-critical changes on production systems such as patching and firmware updates on the last Saturday of every month from 9AM to 9PM.

There have been a few adjustments for holidays and to avoid conflict with the Monthly Information Systems Maintenance (ISM) window.  View timely details of planned or unplanned service interruptions: rc.partners.org/alerts. Sign up for email notifications: rc.partners.org/subscribe.

If you use EndNote on your Mac, please review compatibility before upgrading. EndNote X8 and earlier will not work on your Mac when you upgrade. If you use EndNote X9, please update EndNote before upgrading your Mac. See additional information on the EndNote website. Please see An Update Regarding macOS 10.15 Catalina for additional guidance.

February 12, 2020, 4:30 pm-6:00 pm, Simches Building, Room 3.110, Massachusetts General Hospital

The Mass General Research Institute Entrepreneurs Series is an educational series of talks where our most innovative researchers share their expertise and experience in moving scientific discoveries along the translational pathway to market and patient care. In this session Orhan Muratoglu, PhD, Director of the Harris Orthopaedics Laboratory, will share his journey.

“Commercialization Journey of a Materials Technology to Eliminate Peri-Prosthetic Osteolysis, a Silent Disease Caused by Total Joint Arthroplasty”

To register please visit: https://massgeneral.link/EntrepreneursSeriesMuratoglu

Wednesday, February 26 from 1-4p.m., Assembly Row Training Room 2W23 399 Revolution Drive, Somerville, MA 02145

This is an introductory course to familiarize researchers with the ERISOne Linux Cluster. This is an opportunity for new users to get started in a Linux environment including instruction in command line basic operations, graphical interface, connection and file transfer, permissions and submitting jobs. This hands-on course has limited space, and registration is required.

Thursday, May 7, 2020

10:00 AM – 11:30 AM
Interactive Nursing Research Poster Session
O’KEEFFE AUDITORIUM FOYER, BLAKE 1

Over 50 posters showcasing nurse-lead clinical research, quality improvement, and evidence based practice projects will be displayed!

1:30 PM – 3:00 PM         
Yvonne L. Munn Research Lecture,
Presentation of the 2020 Research &  Poster Awards
O’KEEFFE AUDITORIUM, BLAKE 1

We hope you and your colleagues can join us!

Four Year Award for Investigators
who are Underrepresented in Academic Medicine*
*Fundamental, Clinical, Translational, and Health Services investigators are all eligible

Applications for grants are invited by the MGH Center for Diversity and Inclusion (CDI), and the Executive Committee on Research (ECOR). 

What is the Award?
The MGH Physician/Scientist Development Award (PSDA) is designed for MD and/or PhD investigators at MGH who are considered underrepresented in academic medicine (URiM). This Award is intended to provide transitional funding for support in the development of physicians and scientists underrepresented in academic medicine, and thereby increase opportunities for URiM researchers to advance to senior positions in academic medicine at MGH.  This award is a key faculty initiative of the CDI. We encourage applicants to engage with the center and learn more about our programs and other initiatives: www.massgeneral.org/cdi.The CDI will evaluate the need for this Award on a regular basis.

Am I URiM (Underrepresented in Medicine)?
For the purposes of the PSDA, MGH follows the definition of underrepresented in medicine and biomedical research (URiM) of the NIH and the Association of American Medical Colleges (AAMC).  URM groups may include Latino/ Hispanic (including Brazilian), African-American/Black, American Indian, Native Hawaiian and Alaskan Natives, among others. Please note that Asians are not considered URiM, UNLESS they are underrepresented relative to the population MGH serves, e.g., Cambodian or Laotian.

How much is the award?
Up to $180,000 plus 15% indirect costs, over a three or four-year period, with a maximum of $60,000 plus indirect costs per year for 3 year awards and a maximum of $45,000 plus indirect costs per year for 4 year awards

When is the deadline?
Tuesday, March 17, 2020 – 5:00 PM

How do I learn more and apply?
Click here to read more and apply online

The NIH recently announced Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars. The purpose of this program is to ensure continuity of research among recipients of mentored career development (K) awards by providing supplemental research support to help sustain the investigator’s research during critical life events. Project Directors/Principal Investigators of the following activity codes are eligible for the award: K01, K07, K08, K22, K23, K25, K38, K43, K76, and K99/R00 (on the mentored K99 portion of the K99/R00).

For the purposes of this program, childbirth, adoption, and primary caregiving responsibilities of an ailing spouse, child, partner, or a member of the immediate family during the project period are critical life events that would qualify for consideration. Evidence that the circumstance may affect advancement of the mentored career development award or productivity must be provided. In circumstances in which the critical life event is pending and is expected to occur during the project period, the supplement request may be submitted in advance of the event.

The supplement may be used to support additional personnel, computational services, supplies, and equipment that will promote the continuity of the career development research project during a period in which the PD/PI experiences critical life events which have the potential to impact research progress or potential productivity. Administrative supplements must support work within the scope of the original project.

NOTE: For retention supplements to support first-time NIH R01-Equivalent Awards, see the Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grants, NOT-OD-20-055.

When is the deadline for K award supplements?
Submission dates vary by awarding NIH Institute and Center (IC). See Table of IC-Specific Information and Requirements for more details.

How to Apply
To submit, see the “Application and Submission Information” section of the NIH Notice NOT-OD-20-054, It is strongly recommended that the applicants contact their respective program officers at the NIH Institute/Center supporting the parent award to confirm that the supplement falls within the scope of the parent award.

If you have questions, please contact MGH ECOR at ecor@mgh.harvard.edu or call 617-643-7420.

We are pleased to announce the call for applications for the Partners Healthcare Training Program (T32)  in Precision & Genomic Medicine. The training program is co-led by Jordan W. Smoller, MD, ScD and Heidi Rehm, PhD and supported by the National Human Genome Research Institute (NHGRI).  Our faculty comprise a broad range of leading scientists affiliated with the Partners Healthcare System (including Massachusetts General Hospital and Brigham and Women’s Hospital), Partners Personalized Medicine, Boston Children’s Hospital, the Broad Institute of MIT and Harvard, Harvard Medical School, and the Harvard T.H. Chan School of Public Health.

We seek talented applicants with a commitment to training in the diverse domains of precision and genomic medicine, including medical genetics and genomics, data science, molecular medicine, and implementation science. We are accepting applications for postdoctoral fellows to begin July 1, 2020

The training program brings together three outstanding components for a world-class training program in precision and genomic medicine: 1) an internationally-recognized faculty with expertise in precision and genomic medicine across a broad range of disciplines, 2) outstanding institutional resources bridging clinical, genomic, and data sciences, and 3) deep engagement with cutting edge, collaborative initiatives at the regional, national, and international levels to provide rich training experiences.

Funding is for 2-years and awards cover salary, travel to professional meetings, and other training-related expenses.

Any questions about the T32 program or eligibility can be directed to the Program Manager, Carol Whooley CWHOOLEY1@mgh.harvard.edu. Instructions for assembling the application packet can be found at the program website.

All application materials are due Friday, March 6, 2020 by 5pm ET USA. Notification of awards will be made by April 1, 2020

Deadline: April 1, 2020

We at NORCH are delighted to announce our Request for Applications for our 2020 NORCH Pilot and Feasibility Grant. We are seeking applications for P+F Grants related to Nutrition, Obesity, and Metabolism. The award is $30,000 over 1 year, with possibility for an additional $30,000 during year 2 via a competitive renewal if good progress is achieved. Please visit our website for more details.

Limited Submission Funding Opportunities
We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

• Name of the Principal Investigator with appropriate contact information
• A descriptive title of the potential application
• Brief description of the project
• Brief description of why you specifically should be selected to receive institutional nomination for this award

If there is more than one MGH investigator interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

• Quality Improvement Solutions for Sustained Epidemic Control Project (QISSEC)
• Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional) – NEW!
• Collaborative Program Grant for Multidisciplinary Teams (RM1 – Clinical Trial Optional) – NEW!
• Childhood Asthma in Urban Settings – Clinical Research Centers (U01 Clinical Trial Optional) – NEW!
• Childhood Asthma in Urban Settings – Clinical Research Network – Leadership Center (UM1 Clinical Trial Required) – NEW!

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please let us know at ecor@mgh.harvard.edu.

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

• Name of the Principal Investigator with appropriate contact information
• A descriptive title of the potential application
• Brief description of the project
• Brief description of why you specifically should be selected to receive institutional nomination for this award

If there is more than one MGH investigator interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

• Quality Improvement Solutions for Sustained Epidemic Control Project (QISSEC)
• Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional) – NEW!
• Collaborative Program Grant for Multidisciplinary Teams (RM1 – Clinical Trial Optional) – NEW!
• Childhood Asthma in Urban Settings – Clinical Research Centers (U01 Clinical Trial Optional) – NEW!
• Childhood Asthma in Urban Settings – Clinical Research Network – Leadership Center (UM1 Clinical Trial Required) – NEW!

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please let us know at ecor@mgh.harvard.edu.

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these opportunities.  Note that proposals are still routed through the standard InfoEd/Research Management process.

Please be aware that any grant that brings in less than 15% in indirect costs (IDC) will need to be supplemented up to the 15% equivalent by existing investigator or departmental sundry funds. Resolution of this issue must occur prior to submitting a proposal.  Training fellowships from foundations, public charity, and non-profit organizations are excluded from this minimum IDC requirement.

Week of 2/7/20

• Translational Grant (TRIH Grant), Action on Hearing Loss (Trading Name of the Royal National Institute for Deaf People ([RNID])
• Clinician Scientist Development Grant (CSDG), American Cancer Society (ACS)
• Physician Training Awards in Cancer Prevention, American Cancer Society (ACS)
• Postdoctoral Fellowships, American Cancer Society (ACS)
• Research Scholar Grants, American Cancer Society (ACS)
• RFA: Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families, American Cancer Society (ACS)
• Grants, Jerome Lejeune Foundation
• Grants, Gladys Brooks Foundation
• Clinical Research Grants, Muscular Dystrophy Association (MDA)
• Faculty Grant Program, National Marfan Foundation (NMF)
• Faculty Research Award, Shock Society

NIH Update for Week Ending February 7, 2020

MGH ECOR Formulaic Bridge Funding Support
Application Deadline: February 7, 2020; 7th day of each month

Healthy Aging Research Funding
Application Deadline: February 24

Boston Biomedical Innovation Center (B-BIC) Accepting PILOT & DRIVE Grant Pre-Proposals

PCORI - Click here for the latest funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI).

MGH Research Equipment SharePoint Site

Looking for something you saw in a previous Research News release? Check out our archive!